For generations, the effort to help smokers quit has been a story of modest tools and modest results — patches, gum, and pills that worked, but rarely enough. Now a landmark review of eighty clinical trials has placed nicotine e-cigarettes at the top of that list, doubling quit rates and outperforming every established method. The finding does not resolve all uncertainty — long-term risks remain unmeasured, and the benefit applies only to regulated devices — but it marks a meaningful turn in one of public health's oldest struggles, one that claims more than seven million lives each year.
Nicotine vapes prove most effective smoking cessation aid, Cochrane review finds
Smoking kills over 7 million people annually worldwide; quitting reduces risk of heart disease, lung cancer, and stroke.
Nicotine vapes doubled the success rate for quitting smoking
Mark
Why does this matter now? Haven't vapes been around for years?
Mimi
They have, but this is the first time a major systematic review has looked at all the best evidence together. For a long time, vaping was controversial—people weren't sure if it actually helped people quit. Now we have data from thirty thousand people across eighty trials. The picture is clear.
Mark
So vapes are just better than everything else?
Mimi
Better than the traditional aids, yes. Patches, gum, pills—they work for some people, but not many. Vapes roughly double your chances. But there's a catch: the evidence only applies to regulated devices. The unregulated ones can be dangerous.
Mark
What about the long-term health effects? Isn't that the real question?
Mimi
It is. And honestly, we don't know yet. The review found no evidence of serious harm from using vapes to quit smoking. But vaping hasn't been around long enough for us to know what happens in twenty or thirty years. That's why health authorities are so cautious about children and non-smokers using them.
Mark
If vapes are safer than smoking, why not just let everyone use them?
Mimi
Because the comparison only makes sense if you're already a smoker trying to quit. For someone who's never smoked, vaping introduces nicotine and other chemicals into their body for no reason. The benefit only exists if you're replacing smoking with vaping.
Mark
What happens next? Does this change how the NHS operates?
Mimi
Most NHS services already offer vapes. This review gives them stronger evidence to do so. But the real work now is making sure people use regulated devices and understanding what the long-term picture looks like.
The Pulse
- A Cochrane review of nearly thirty thousand participants has found nicotine vapes double smoking quit rates, lifting success from six percent to ten — a modest number that represents millions of lives.
- The finding disrupts the long-standing hierarchy of cessation tools, potentially displacing patches, gum, and even the newly distributed anti-smoking pill cytisine from the top of clinical recommendations.
- A critical fault line runs through the evidence: the benefit applies only to regulated, quality-checked devices, while unregulated vapes — which may contain spice, THC, or unstable batteries — carry serious and unquantified dangers.
- Britain's smoking landscape has already quietly shifted, with vape users now outnumbering cigarette smokers for the first time, and nearly every NHS stop-smoking service now offering approved devices.
- Health authorities are drawing a firm boundary: while vaping is far safer than smoking for existing smokers, children and non-smokers should never use these devices, and long-term risks remain an open and urgent question.
For generations, the effort to help smokers quit has been a story of modest tools and modest results — patches, gum, and pills that worked, but rarely enough. Now a landmark review of eighty clinical trials has placed nicotine e-cigarettes at the top of that list, doubling quit rates and outperforming every established method. The finding does not resolve all uncertainty — long-term risks remain unmeasured, and the benefit applies only to regulated devices — but it marks a meaningful turn in one of public health's oldest struggles, one that claims more than seven million lives each year.
For decades, the standard tools for quitting smoking — patches, gum, prescription pills — have worked, but not well. Around six in every hundred people who try them stay quit. A sweeping new Cochrane review of eighty trials and nearly thirty thousand participants now suggests something better exists: nicotine e-cigarettes, which doubled that success rate to roughly ten percent, outperforming every traditional method and potentially even cytisine, the newer anti-smoking pill the NHS has recently begun distributing.
The finding lands at a telling moment. For the first time, more British adults now use e-cigarettes than smoke traditional cigarettes — 5.4 million vapers against 5.3 million smokers. The shift has been quiet but consequential, and the review gives it a degree of clinical validation it has not previously had.
But the evidence carries a firm condition. It applies only to regulated vapes — devices tested for quality and approved by national safety bodies. Unregulated e-cigarettes can contain illicit substances and pose genuine chemical and physical dangers. Researchers and clinicians alike urge that anyone using vaping to quit should purchase only approved devices.
The broader stakes are not abstract. Smoking kills more than seven million people worldwide each year, and in Britain, roughly two in three long-term smokers will die from a tobacco-related illness. Quitting at any age meaningfully reduces the risk of heart disease, lung cancer, and stroke. Long-term vaping risks remain unclear, and health authorities are unambiguous that children and non-smokers should never vape. But for the millions trying to quit, nearly every NHS stop-smoking service in the country now offers access to approved devices — searchable by postcode.
For decades, the tools for quitting smoking have remained largely the same: nicotine patches stuck to skin, gum chewed throughout the day, prescription pills taken with breakfast. They work, but not well. Around six out of every hundred people who try them actually stay quit. Now a sweeping review of the evidence suggests there is something better—and it comes in the form of the devices many smokers have already turned to.
Researchers at Cochrane, an organization that synthesizes the world's best medical evidence, examined eighty major trials involving nearly thirty thousand people. What they found was striking: nicotine e-cigarettes doubled the success rate for quitting smoking, lifting it from six percent to roughly ten percent. They outperformed patches, gum, and traditional support programs. They also beat non-nicotine vapes, though researchers note that switching to those devices afterward might help people gradually step away from nicotine altogether.
The review even suggests nicotine vapes could prove more effective than cytisine, a newer anti-smoking pill that the NHS has begun distributing across the country. But that comparison remains preliminary—more research is needed to be certain. What is clear is that among the tools currently available, nicotine vapes represent the most reliable path to quitting for most people who try them.
The finding arrives at a moment when vaping has already reshaped the landscape of smoking in Britain. For the first time, more adults now use e-cigarettes than smoke traditional cigarettes. Around 5.3 million people, roughly ten percent of the adult population, identify as smokers. By contrast, 5.4 million people use vapes daily or occasionally. The shift has been quiet but profound.
Yet the review comes with important caveats. The evidence applies only to regulated vapes—devices that have been tested for quality and comply with strict safety standards. Unregulated e-cigarettes, which can contain illicit substances like spice or THC, pose genuine dangers, including unstable batteries and harmful chemicals. Dr. Jamie Hartmann-Boyce, one of the authors of the review, emphasized that anyone considering vaping to quit smoking should purchase only devices approved by their country's regulatory body.
Experts stress that vaping, while not entirely without risk, is far safer than smoking. The review found no evidence of increased serious harm from using e-cigarettes to quit. But the long-term risks of vaping remain unclear, and health authorities are firm on one point: children and non-smokers should never vape. Doctors worry that vaping could cause health problems in young people and say the devices should be made less appealing to them.
The stakes of quitting are enormous. Smoking kills more than seven million people annually worldwide, according to the World Health Organization, making it the leading cause of preventable death. In Britain, roughly two in three long-term smokers will die from a tobacco-related illness. Quitting, even late in life, dramatically reduces the risk of heart disease, lung cancer, and stroke. For most people, the choice is not between perfect and imperfect—it is between a tool that works and one that does not. For many, that tool is now a vape. Nearly every NHS stop-smoking service in the country now offers vapes or other support to help people quit, and the services are searchable by postcode online.
Notable Quotes
Unlicensed e-cigarettes are potentially dangerous, with issues including unstable batteries and harmful chemicals. Anyone looking to use e-cigarettes to quit smoking should only purchase devices that have been tested and approved by their country's regulatory body.— Dr. Jamie Hartmann-Boyce, Cochrane review author
Want the full story?
Read the original at BBC News ↗
Science & Space